BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1154259)

  • 1. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
    Holmes EC; Roth JA; Morton DL
    Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of soluble human melanoma-associated antigens.
    Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
    Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
    Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
    J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF; Wells SA; Herberman RB
    Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.
    Roth JA; Grimm EA; Morton DL
    Cancer Res; 1976 Sep; 36(9 pt.1):3001-10. PubMed ID: 975069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of tumor-associated antigen in human melanoma cell line supernatants.
    Grimm EA; Silver HK; Roth JA; Chee DO; Gupta RK; Morton DL
    Int J Cancer; 1976 May; 17(5):559-64. PubMed ID: 1270174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma.
    Char DH; Hollinshead A; Cogan DG; Ballintine EJ; Hogan MJ; Herberman RB
    N Engl J Med; 1974 Aug; 291(6):274-7. PubMed ID: 4407111
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA; Melewicz FC; Christiansen C; Ketcham AS
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract]   [Full Text] [Related]  

  • 10. Human carcinoma antigens cross reacting with anti-embryonic antibodies.
    Klavins JV; Mesa-Tejada R; Weiss M
    Nat New Biol; 1971 Dec; 234(48):153-4. PubMed ID: 4332180
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo delayed hypersensitivity reactions to partially purified human melanoma antigens.
    Sutherland CM; Leong SP; Cooperband SR; Deckers PJ; Hornung MO; Krementz ET
    J Surg Oncol; 1982 Aug; 20(4):221-6. PubMed ID: 7109625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA; Rimoldi D; LiƩnard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a soluble tumor-associated antigen from human melanoma.
    Roth JA; Holmes EC; Reisfeld RA; Slocum HK; Morton DL
    Cancer; 1976 Jan; 37(1):104-10. PubMed ID: 1247946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
    Hollinshead AC; Stewart TH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

  • 18. Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.
    Freedman RS; Bowen JM; Atkinson EN; Scott W; Wagner S
    Cancer Immunol Immunother; 1984; 17(2):142-6. PubMed ID: 6088033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed cutaneous hypersensitivity reactions to tumor extracts in patients with cervical carcinoma.
    Melewicz FC; Wells SA; Christiansen C; Ketcham A
    Surg Forum; 1972; 23(0):94-6. PubMed ID: 4671036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.